Madrid, Spain

Jesus G Garcia

This inventor holds 1 USPTO granted patent. Top assignee: Laboratories Knoll, S.a.. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jesus G Garcia. Retrieved from https://idiyas.com/inventor/jesus-g-garcia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jesus G Garcia

Introduction

Jesus G Garcia is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of medicine, particularly in the treatment of leukemias. His innovative approach has led to the development of a unique method that utilizes a specific compound for effective treatment.

Latest Patents

Garcia holds a patent for a method for treating leukemias using N-(2-dimethylaminoethyl)-3-amino-1,8-naphthalimide, commonly known as amonafide. This compound has been identified as an effective agent for the treatment of leukemias and solid tumors. His work in this area showcases his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Garcia is associated with Laboratories Knoll, S.A., where he continues to work on innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Throughout his career, Garcia has collaborated with esteemed colleagues, including Miguel Fernandez Brana and Antonio M Sanz. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.

Conclusion

Jesus G Garcia's contributions to the field of medicine through his innovative patent demonstrate his expertise and commitment to improving treatment options for patients. His work continues to inspire future advancements in medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…